$HNGE

Mecklenburg Gabriel M.I. sold $67K of HNGE

Mecklenburg Gabriel M.I. sold 1,200 shares of Hinge Health, Inc. (HNGE) at $55.74 on 2026-06-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Mecklenburg Gabriel M.I.
Published Jun 3, 2026, 8:23 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 3, 2026, 8:36 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$HNGE
Neutral
medium confidence
Mentioned
$HNGE
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HNGENeutralLow
01

Why it matters

The disclosure updates the insider ownership record but does not, by itself, change company fundamentals or guidance.

02

Market read

Traders may monitor insider activity as a sentiment input, but 10b5-1 structure typically limits interpretive power.

03

What to watch

The article provides only the sale size and price; it does not indicate whether other insiders increased/decreased holdings around the same time.

Relevance 7/10Novelty 6/10Timing: Filed June 3; sale executed June 1 under a 10b5-1 plan

Background

This is an SEC Form 4 insider transaction disclosure for Hinge Health, Inc. (HNGE).

Company-level read

Ticker impact

$HNGENeutralMedium confidence
Context

Hinge Health director sold 1,200 shares in an open-market transaction under a pre-arranged 10b5-1 plan, disclosing $66,890.52 proceeds.

Expected impact

Low near-term impact; any reaction is likely sentiment-driven and short-lived.

Evidence & confidence

The filing is a routine 10b5-1 sale with no accompanying operational or financial catalyst in the article.

Market effects

Minimal—single-company insider transaction without sector-wide news.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish expectations.

Key entities

  • Hinge Health, Inc.

    Subject of the Form 4 insider sale; director sold 1,200 shares on June 1, 2026 under a 10b5-1 plan.

  • Mecklenburg Gabriel M.I.

    Director who executed the open-market sale; holdings after transaction: 82,134 shares.

Related articles

$HNGEHighAI 9/10

Why is Hinge Health stock surging today?

Hinge Health (HNGE) shares rose 11.6% after the company reported Q2 2026 revenue of $212.8M (+53% YoY) and non-GAAP diluted EPS of $0.59 vs $0.13 consensus. Free cash flow exceeded $100M. Hinge raised FY2026 revenue guidance to $818M-$824M and Q3 guidance to $223M-$225M, and agreed to buy Cylinder Health for $105M cash. Analysts lifted price targets.

$HNGELowAI 8/10

Jim Cramer Says Hinge Health “Delivered a True Blowout Set of Numbers”

On Jim Cramer’s “Mad Money,” he discussed Hinge Health (NYSE:HNGE) after the company reported strong results. Cramer said revenue rose 47% year over year, margins beat expectations, and earnings topped estimates. He noted management raised current-quarter guidance and substantially lifted the full-year forecast, and the stock jumped about 10% in one session, then traded sideways.